Specialized Expertise Triangle Biostatistics boasts a highly experienced consulting team with an average of 15 years in pharmaceutical biostatistics, positioning it as a trusted partner for complex regulatory submissions and data management projects in drug development.

Acquisition Opportunity The company's recent acquisition by Catalyst Clinical Research indicates potential for expanded resources and integration efforts, making it an attractive target for service expansion and strategic partnerships in clinical trial support.

Flexible Engagement Models Offering staff augmentation, time and materials, and fixed-price models allows for tailored solutions to potential clients across various stages of clinical development, increasing opportunities for sales in multiple service categories.

Mid-Market Position With revenue between 1M and 10M and a specialized niche, Triangle Biostatistics presents a growth opportunity for larger firms targeting niche service providers or for smaller competitors seeking to expand their project capacity.

Market Alignment Operating within the pharmaceutical manufacturing and clinical trial support sectors, the company is well-positioned to tap into current market trends emphasizing regulatory expertise and innovative biostatistical solutions, appealing to both large and emerging pharmaceutical companies.